Omicron COVID booster cuts hospitalization in over 65s -- Israeli study

Omicron COVID booster cuts hospitalization in over 65s, Israeli study finds The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab's real-world effectiveness. Reuters Reuters

It (the study)  found an 81% reduction in hospitalizations among people aged 65 and older who had received the booster against those who had previously received at least two COVID vaccinations, but not the Omicron-adapted shot.

...